CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) shares shot up 48.3% on Wednesday. The stock traded as high as $20.00 and last traded at $20.00. Approximately 100 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 729 shares. The stock had previously closed at $13.49.
CellaVision AB (publ) Stock Performance
The firm’s fifty day moving average price is $14.39 and its two-hundred day moving average price is $14.70.
CellaVision AB (publ) Company Profile
CellaVision AB develops digital microscopy solutions for clinical laboratories, with a focus on blood cell analysis in hematology. Its systems help laboratory professionals examine and classify blood cells and support the review of cell morphology.
The company’s offerings combine automated imaging instruments with software for image analysis and review. These tools are designed to support laboratory workflows, including the assessment of blood-cell differentials, and can help specialists collaborate on results.
Founded in 1994 and headquartered in Lund, Sweden, CellaVision serves customers internationally through a global sales and distribution network.
Recommended Stories
- Five stocks we like better than CellaVision AB (publ)
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
